Rein Therapeutics (RNTX) Metrics: History & Chart

Rein Therapeutics Inc.(RNTX)

Biotechnology · Austin, TX

$0.82-0.01 (-0.65%)

Delayed quote: Oct 6, 2026, 1:30 PM EDT

About Rein Therapeutics Inc.

Rein Therapeutics Inc. operates as a clinical-stage biopharmaceutical enterprise focused on discovering and bringing to market novel therapeutic solutions for various conditions, notably cancer. The company's leading drug candidate, ALRN-6924, is a distinctive cell-penetrating peptide. This compound works by disrupting the harmful interaction between the p53 suppressor proteins, MDM2 and MDMX, and the vital p53 tumor suppressor. Its goal is to reactivate the natural tumor-suppressing pathways in cancers where the p53 gene is still functional, or "wild-type." The organization was founded on August 6, 2001, by Gregory L. Verdine, Rosana Kapeller, Huw M. Nash, Joseph A. Yanchik III, and Loren David Walensky, and its main corporate offices are situated in Austin, Texas.

Austin, TX

10 employees

www.reintx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: James Brian Windsor

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+14.42%
30D Total Return	-7.21%
YTD Total Return	-28.88%
1Y Total Return	-30.67%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	-28.88%
2025	-49.57%
2024	N/A
2023	N/A
2022	N/A
2021	N/A

CAGR TTM	-30.55%
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

RNTX Valuation Metrics

RNTX Stock Price Metrics

RNTX Dividend Metrics

RNTX Growth Rate Metrics

RNTX Discounted Cash Flow Metrics

RNTX Returns By Period

RNTX Yearly Returns

RNTX Average Annual Returns By Period (CAGR)

RNTX Revenue Metrics

RNTX PE Ratio Metrics

RNTX PS Ratio Metrics

RNTX PB Ratio Metrics

RNTX Price to Free Cash Flow Ratio Metrics

RNTX Debt to Equity Ratio Metrics

RNTX PEG Ratio Metrics

RNTX FCF Yield

RNTX Earnings Yield

RNTX EBITDA Yield

RNTX OCF Yield

RNTX EV/EBIT Ratio Metrics

RNTX EV/EBITDA Ratio Metrics

RNTX EV/Assets Ratio Metrics

RNTX EV/Sales Ratio Metrics

RNTX Current Ratio Metrics

RNTX Quick Ratio Metrics

RNTX ROIC Metrics

RNTX Return on Assets Metrics

RNTX Return on Equity Metrics

RNTX Net Profit Margin Metrics

RNTX Gross Profit Margin Metrics

RNTX Tax Rate Metrics

PS Ratio	N/A
PS Ratio Avg TTM	N/A
PS Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

PB Ratio	2.46
PB Ratio Avg TTM	19.27
PB Ratio Avg 3Y	11.57
Current VS TTM Avg	-87.24%
Current VS 3Y Avg	-78.74%
Current VS 5Y Avg	-78.74%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.08
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	-100.00%
Current VS 3Y Avg	N/A
Current VS 5Y Avg	-100.00%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	0.25
Ev/Assets Ratio Avg TTM	0.74
Ev/Assets Ratio Avg 3Y	0.50
Current VS TTM Avg	-66.33%
Current VS 3Y Avg	-50.37%
Current VS 5Y Avg	-50.37%

Ev/Sales Ratio	N/A
Ev/Sales Ratio Avg TTM	N/A
Ev/Sales Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Current Ratio	4.27
Current Ratio Avg TTM	1.43
Current Ratio Avg 3Y	2.81
Current VS TTM Avg	+199.48%
Current VS 3Y Avg	+51.81%
Current VS 5Y Avg	-23.12%

Quick Ratio	4.27
Quick Ratio Avg TTM	1.43
Quick Ratio Avg 3Y	2.81
Current VS TTM Avg	+199.48%
Current VS 3Y Avg	+51.81%
Current VS 5Y Avg	-23.12%

ROIC	(36.89%)
ROIC Avg 3Y	(43.88%)
ROIC Avg 5Y	(43.88%)
Current VS 3Y Avg	+15.92%
Current VS 5Y Avg	+15.92%
Current VS 10Y Avg	+15.92%

ROA	(75.43%)
ROA Avg TTM	(37.29%)
ROA Avg 3Y	(6.30%)
Current VS TTM Avg	-102.27%
Current VS 3Y Avg	-1096.67%
Current VS 5Y Avg	-1966.97%

ROE	(487.90%)
ROE Avg TTM	(335.83%)
ROE Avg 3Y	(156.07%)
Current VS TTM Avg	-45.28%
Current VS 3Y Avg	-212.62%
Current VS 5Y Avg	-512.95%

Net Profit Margin	0.00%
Net Profit Margin Avg TTM	0.00%
Net Profit Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Gross Profit Margin	0.00%
Gross Pft Margin Avg TTM	0.00%
Gross Pft Margin Avg 3Y	0.00%
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Tax Rate	1.41%
Tax Rate Avg 3Y	0.95%
Tax Rate Avg 5Y	0.63%
Current VS 3Y Avg	+48.03%
Current VS 5Y Avg	+122.05%
Current VS 10Y Avg	+122.05%